Subgroups
Outcomes (5)
- biomarker-glucose-fasting-serum-target-below-109-mg-per-dl-achieved-binary-measured
- biomarker-glucose-fasting-serum-target-below-109-mg-per-dl-achieved-binary-self-reported
- biomarker-glucose-fasting-serum-target-below-125-mg-per-dl-achieved-binary-measured
- biomarker-glucose-fasting-serum-target-in-range-100-to-116-mg-per-dl-achieved-binary-measured
- biomarker-glucose-fasting-serum-target-in-range-80-to-100-mg-per-dl-overnight-achieved-binary-self-reported
Protocols & scoring
medication-diabetes-insulin-degludec-basal-generic2 evidence rows
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-glucose-fasting-serum-target-in-range-100-to-116-mg-per-dl-achieved-binary-measured | +50 | 25 | 1 |
medication-diabetes-insulin-degludec-evening-low-dose-metformin-diet-carbohydrate-low-combined1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-glucose-fasting-serum-target-below-109-mg-per-dl-achieved-binary-measured | +60 | 25 | 1 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-glucose-fasting-serum-target-below-125-mg-per-dl-achieved-binary-measured | +40 | 35 | 1 |
Path: biomarker › glucose › fasting › serum › target